Denemek ALTIN - Özgür
Conference 'understanding Regulatory Perspectives Of Excipients' Hosted By Ipec
Express Pharma
|August 16-31, 2019
Experts, manufacturers and consumers attending the conference discussed the ever-evolving regulatory framework that guides the Indian excipients industry how active communication between the suppliers and users can decrease instances of quality negligence
-
THE INTERNATIONAL
Pharmaceutical Excipients Council (IPEC) recently organised a conference to boost communication and understanding between manufacturers and consumers involved in the supply chain for the excipients segment. Held in Mumbai, the theme of the one-day conference was 'Understanding Regulatory Perspectives of Excipients'. Speakers and experts attending the conference also discussed the ever-evolving regulatory framework that guides the Indian excipients industry and the need for Indian manufacturers to diligently adopt global GMP standards in times when they are facing stiff competition from China, USA and Europe.
Commenting on this the issue, Subodh Priolkar, Vice Chairman, IPEC India and CEO, Wincoat Colours and Coatings, spoke during his welcome address, “The Chinese Pharmacopoeia has included functional related characteristics (FRC) in a monograph which will create imbalance under the current regulatory regime. But this would definitely help excipients to perform critical functional attributes for drug safety. These are particle size, mean particle size, bulk density, viscosity, etc besides assay and chemical test. The challenge that lies in this context is that regulated markets cannot modify GMP Requirements for Certificates of Analysis (CoA) and according to Chinese regulations basis if there is a special material manufactured in China as per the local regulations. Just as if any regulated market comes out with a regulation on elemental impurities to comply with, it would be really difficult to comply when we are talking about global regulatory harmonisation.”
Bu hikaye Express Pharma dergisinin August 16-31, 2019 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Express Pharma'den DAHA FAZLA HİKAYE
Express Pharma
Speed and flexibility play a critical role in how we compete with larger global players
Kriti Jajoo, VP-BD and Strategy, Shriji Polymers, as the next-gen leader, speaks on how the company is evolving with a leadership approach that balances technology, sustainability, and customer-centricity to create long-term value, in an interview with Express Pharma
6 mins
January 2026
Express Pharma
Vizag rising: Shaping India's pharma future
At the Vizag Pharma Summit 2025, hosted by Express Pharma, industry leaders discussed how quality, R&D, compliance, and emerging technologies are driving India's next phase of pharma growth
9 mins
January 2026
Express Pharma
Future of pharma: Trends, challenges & AI
Industry experts discussed how Al is transforming pharmaceutical R&D, highlighting both the promise and the practical limitations of current technologies
2 mins
January 2026
Express Pharma
Gandhi Automations presents multi-composites, high-performance door PRIME NEO for clean environments
When it comes to pharmaceutical facilities and laboratories, clean rooms' hygiene and protection from environmental contamination are the most important factors to consider.
1 mins
January 2026
Express Pharma
Can Indian biosimilars and generics restate accessibility in global underserved markets?
Hari Kiran Chereddi, MD & CEO - HRV Pharma & NHG Pharma highlights that India's success in generics is no longer enough, as the world now demands advanced biologics, biosimilars, and personalised medicines. He further emphasises on the need for stronger regulation, innovation, and investment so India can lead in next-generation therapies and expand global access to cutting-edge healthcare
3 mins
January 2026
Express Pharma
The next wave of growth will belong not to the fastest manufacturers but to the most innovative problem-solvers
As India moves into 2026, industry experts state that the next phase of growth in pharmaceuticals will depend on strengthening formulation R&D, building a skilled and adaptable workforce, and closing gaps between academic research and industry needs.
6 mins
January 2026
Express Pharma
Results win customers. Leadership discipline keeps them
Drawing themes from his new book The Dual Mandate in B2B - Driving Results. Shaping Culture, Mohan Joshi - Global C-Suite Partner & Former President, SCHOTT India, discusses leadership systems, alignment, and execution in conversation with Neha Aathavale.
3 mins
January 2026
Express Pharma
INDIA'S INNOVATION JOURNEY FROM PROMISE TO PROOF
India's pharma ecosystem is ready to embrace stronger science and bolder ideas. Turning early breakthroughs into scalable, sustainable innovation remains the challenge
8 mins
January 2026
Express Pharma
PRUV® -The original Sodium Stearyl Fumarate
JRS Pharma's PRUV® is the original sodium stearyl fumarate (SSF) introduced in the market over 20 years ago
5 mins
January 2026
Express Pharma
Odisha's pharma pitch
The inaugural Odisha Pharma Summit 2025 delivered strong early signals of intent, positioning the state as an upcoming destination for PLI-triggered expansions, to complement existing pharma hubs. As Hemant Sharma, ACS Industry Dept and I&PR Dept, Govt of Odisha puts it, the aim is to “become a good, viable second option.” How fast can the eastern newcomer catch up and become India's next life sciences hub, asks Viveka Roychowdhury
5 mins
January 2026
Translate
Change font size
